• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Drug Policy

    Tag: Drug Policy

    U.S. deterrence policy has generated plenty of criticism from Capitol Hill. But that has been aimed at the administration's supposedly narrow view of what constitutes an attack and unwillingness to spell out likely responses.
    Healthcare

    Medicare Part D benefit design leads to higher costs for specialty drugs

    David Hogberg -
    June 4, 2021 3:00 am
    0
    Overdose deaths during pandemic may be linked to mental healthcare access
    News

    Overdose deaths during pandemic may be linked to mental healthcare access

    David Hogberg -
    May 24, 2021 12:00 am
    0
    U.S. deterrence policy has generated plenty of criticism from Capitol Hill. But that has been aimed at the administration's supposedly narrow view of what constitutes an attack and unwillingness to spell out likely responses.
    Business

    Congress takes aim again at pharmaceutical giant over patent-stacking for brand-name drugs

    Cassidy Morrison -
    May 21, 2021 3:00 am
    0
    Democratic drug reform bill could sacrifice future savings to keep costs down
    News

    Democratic drug reform bill could sacrifice future savings to keep costs down

    David Hogberg -
    May 21, 2021 12:00 am
    0
    Retired public school teacher Gail Orcutt, of Altoona, Iowa, holds some of the prescription drugs she takes, Friday, Feb. 15, 2019, in Altoona, Iowa.
    Healthcare

    Democratic reform plans risk slowing new drug development

    David Hogberg -
    May 14, 2021 10:30 am
    0
    U.S. deterrence policy has generated plenty of criticism from Capitol Hill. But that has been aimed at the administration's supposedly narrow view of what constitutes an attack and unwillingness to spell out likely responses.
    Healthcare

    Biden pressured to overhaul addiction treatment due to skyrocketing rates of opioid overdoses

    Cassidy Morrison -
    May 7, 2021 3:00 am
    0
    Numbers clearly refute Biden’s call for government pricing in Medicare drug plan
    Beltway Confidential

    Numbers clearly refute Biden’s call for government pricing in Medicare drug plan

    Quin Hillyer -
    April 30, 2021 2:52 am
    0
    Biden endorses controversial drug pricing plan to pay for Obamacare
    Healthcare

    Biden endorses controversial drug pricing plan to pay for Obamacare

    Cassidy Morrison -
    April 29, 2021 2:47 am
    0
    Biden administration liberalizes use of addiction treatment buprenorphine amid opioid crisis
    Healthcare

    Biden administration liberalizes use of addiction treatment buprenorphine amid opioid crisis

    Cassidy Morrison -
    April 27, 2021 4:04 pm
    0
    Vanita Gupta’s troubling corporate ties make her the wrong choice for associate attorney general
    Op-Eds

    Vanita Gupta’s troubling corporate ties make her the wrong choice for associate attorney general

    Carrie Severino -
    April 15, 2021 4:00 am
    0
    1...151617...21Page 16 of 21
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.